This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n6http://linked.opendata.cz/resource/drugbank/drug/DB08967/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/atc/
n7http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB08967
rdf:type
n3:Drug
n3:description
Dimetotiazine has considerable antiemetic & serotonin antagonistic action used mainly in allergic skin conditions.
n3:group
approved
owl:sameAs
n10:DB08967
dcterms:title
Dimetotiazine
adms:identifier
n6:DB08967
n3:synthesisReference
British Patent 814,512.
n3:IUPAC-Name
n4:271B6096-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B609C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B609B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6098-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6099-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B609A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6094-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6095-363D-11E5-9242-09173F13E4C5 n4:271B6092-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6093-363D-11E5-9242-09173F13E4C5
n7:hasATCCode
n8:N02CX05
n3:H-Bond-Acceptor-Count
n4:271B60A2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B60A3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B609D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B609E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B60A0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B609F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B60A1-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
7456-24-8
n3:Bioavailability
n4:271B60A7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B60A9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B60AA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B60A6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B60A5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B60A8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6097-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B60A4-363D-11E5-9242-09173F13E4C5